How complement activation via a C3a receptor pathway alters CD4+T lymphocytes and mediates lung cancer progression? -future perspectives

被引：1
|
作者：
Magalhaes Filho, Marcos [1 ]
Aguiar Junior, Pedro Nazareth [1 ,2 ]
Adashek, Jacob J. [3 ]
De Mello, Ramon Andrade [4 ,5 ,6 ]
机构：
[1] Fac Med ABC, Santo Andre, Brazil
[2] Amer Ctr Oncol Integrado, Sao Paulo, Brazil
[3] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA
[4] State Hosp Bauru, Dept Med Oncol, Sao Paulo, Brazil
[5] Univ Nove Julho, Fac Med, Sao Paulo, Brazil
[6] Univ Algarve, Dept Ciencias Biomed & Med, Faro, Portugal
来源：
JOURNAL OF THORACIC DISEASE | 2019年 / 11卷
关键词：
D O I：
10.21037/jtd.2019.02.21
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：S210 / S211
页数：2
相关论文
共 16 条
  • [1] Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression
    Kwak, Jeff W.
    Laskowski, Jennifer
    Li, Howard Y.
    McSharry, Maria V.
    Sippel, Trisha R.
    Bullock, Bonnie L.
    Johnson, Amber M.
    Poczobutt, Joanna M.
    Neuwelt, Alexander J.
    Malkoski, Stephen P.
    Weiser-Evans, Mary C.
    Lambris, John D.
    Clambey, Eric T.
    Thurman, Joshua M.
    Nemenoff, Raphael A.
    CANCER RESEARCH, 2018, 78 (01) : 143 - 156
  • [2] COMPLEMENT RECEPTOR-2, WHICH MEDIATES COMPLEMENT ENHANCEMENT OF HIV-INFECTION INVITRO, IS EXPRESSED INVIVO ON A SUBSET OF CD4+T LYMPHOCYTES
    JUNE, RA
    STEFANIK, K
    LANDAY, AL
    LINT, TF
    SPEAR, GT
    FASEB JOURNAL, 1991, 5 (04): : A597 - A597
  • [3] The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses
    Nabizadeh, Jamileh A.
    Manthey, Helga D.
    Steyn, Frederik J.
    Chen, Weiyu
    Widiapradja, Alexander
    Akhir, Fazrena N. Md
    Boyle, Glen M.
    Taylor, Stephen M.
    Woodruff, Trent M.
    Rolfe, Barbara E.
    JOURNAL OF IMMUNOLOGY, 2016, 196 (11): : 4783 - 4792
  • [4] The complement C3a receptor contributes to melanoma tumourigenesis by regulating neutrophil and CD4+ T cell responses
    Nabizadeh, J.
    Manthey, H.
    Boyle, G.
    Steyn, F.
    Woodruff, T.
    Rolfe, B.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2016, 46 : 510 - 510
  • [5] Adenosine A2A receptor activation on CD4+T lymphocytes and neutrophils attenuates lung ischemia-reperfusion injury
    Sharma, Ashish K.
    Laubach, Victor E.
    Ramos, Susan I.
    Zhao, Yunge
    Stukenborg, George
    Linden, Joel
    Kron, Irving L.
    Yang, Zequan
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2010, 139 (02): : 474 - 482
  • [6] The death receptor Fas mediates a non-apoptotic signaling cascade in apoptosis resistant CD4+T cells via the MAPK pathway.
    Ramaswamy, Madhu
    Cruz, Anthony
    Barden, Mary
    Siegel, Richard
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [7] MiR-195 Restrains Lung Adenocarcinoma via Regulating CD4+T Cell Activation Through CCDC88C/Wnt Signaling Pathway
    Yuan, C.
    Xie, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S475 - S476
  • [8] Biotin deficiency induces Th1 and Th17 mediated inflammatory response in CD4+T lymphocytes via activation of mTOR signaling pathway
    Elahi, Asif
    Sabui, Subrata
    Agrawal, Anshu
    Said, Hamid M.
    FASEB JOURNAL, 2018, 32 (01):
  • [9] CELL CYCLE REGULATION VIA P21 PATHWAY MEDIATES CD4+T CELL EXHAUSTION DURING ANTI-TUMOR RESPONSE IN COLORECTAL CANCER
    Thoma, Oana-Maria
    Naschberger, Elisabeth
    Larafa, Imen
    Britzen-Laurent, Nathalie
    Merkel, Susanne
    Grutzmann, Robert
    Sturzl, Michael
    Neurath, Markus
    Waldner, Maximilian
    GASTROENTEROLOGY, 2024, 166 (05) : S186 - S186
  • [10] MiR-195 restrains lung adenocarcinoma by regulating CD4+T cell activation via the CCDC88C/Wnt signaling pathway: a study based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and bioinformatic analysis
    Yuan, Cheng
    Xiang, Liyang
    Bai, Rui
    Cao, Kuo
    Gao, Yanping
    Jiang, Xueping
    Zhang, Nannan
    Gong, Yan
    Xie, Conghua
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (12)
12